Akebia Therapeutics, Inc. AKBA
- ebribafusp — C3 Glomerulopathy Phase 2
- ebribafusp — IgA Nephropathy Phase 2
- ebribafusp — Lupus Nephritis Phase 2
C3d (2 companies · 4 programs)
Companies with an active program directed at C3d.
Q32 Bio Inc. QTTB
- ADX-096 Preclinical